Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Tanise Shattock"'
Publikováno v:
Crystal Growth & Design. 10:4630-4637
We demonstrate the effectiveness and accuracy of high resolution powder diffraction for determination of cocrystal structures through a double-blind study. Structures of 10 cocrystals of varying complexity were determined independently using single c
Publikováno v:
Crystal Growth & Design. 9:1106-1123
The reliability of solvent drop grinding (SDG), also referred to as liquid assisted grinding, wet cogrinding, or mechanochemistry, to facilitate cocrystal formation is addressed with a series of model cocrystals and pharmaceutical cocrystals. The syn
Publikováno v:
Crystal Growth & Design. 8:4533-4545
A Cambridge Structural Database (CSD) analysis was conducted in order to evaluate the hierarchy of supramolecular heterosynthons that involve two of the most relevant functional groups in the context of active pharmaceutical ingredients, carboxylic a
Publikováno v:
Crystal Growth & Design. 5:2046-2049
The 2:3 co-crystal of trimesic acid and 1,2-bis(4-pyridyl)ethane (2) exhibits concomitant polymorphism. Form II of 2 is the expected hexagonal (6,3) network, whereas form I is a (10,3)-a network that exhibits an unprecedented 18-fold level of interpe
Autor:
Michael J. Zaworotko, Joanna A. Bis, Olga L. Mclaughlin, Peddy Vishweshwar, Jennifer A. McMahon, Tanise Shattock
Publikováno v:
Zeitschrift für Kristallographie - Crystalline Materials. 220:340-350
A Cambridge Structural Database study of supramolecular synthons involving primary amides reveals that 84% form amide-amide dimers, whereas 14% form catemers in the absence of other competing hydrogen bond donors and/or acceptors. However in the pres
Crystal engineering of pharmaceutical co-crystals from polymorphic active pharmaceutical ingredients
Autor:
Magali B. Hickey, Tanise Shattock, Michael J. Zaworotko, Matthew Peterson, Peddy Vishweshwar, Jennifer A. McMahon
Publikováno v:
Chemical communications (Cambridge, England). (36)
The carboxylic acid-primary amide supramolecular heterosynthon is exploited for the generation of pharmaceutical co-crystals that contain two active pharmaceutical ingredients that are polymorphic in their pure forms.
Publikováno v:
Crystal Growth & Design; Feb2009, Vol. 9 Issue 2, p1106-1123, 18p